skylive entertainment group – Trademark Portfolio
Entity Type: 16
skylive entertainment group holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include BREAKTHROUGH BREATHWORK and ELEVATE MINDSET MASTERY. The owner is based in alhambra, CA.
88 s garfield avenue, 251
alhambra, CA 91801
Showing of trademarks Trademarks
Trademark Classifications
skylive entertainment group's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does skylive entertainment group have?
skylive entertainment group has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 1 cancelled.
What trademark classes does skylive entertainment group file in?
skylive entertainment group files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are skylive entertainment group's most well-known trademarks?
skylive entertainment group's registered trademark portfolio includes well-known marks such as BREAKTHROUGH BREATHWORK and ELEVATE MINDSET MASTERY. These are among 2 currently registered trademarks in the portfolio.
What is skylive entertainment group's trademark registration success rate?
skylive entertainment group has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.